KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,887 | -52.5% | 37,330 | -21.4% | 0.00% | 0.0% |
| Q2 2023 | $1,091,542 | +4.3% | 47,479 | +34.4% | 0.00% | 0.0% |
| Q1 2023 | $1,046,858 | +30.0% | 35,331 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $805,335 | +16.9% | 32,265 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $689,000 | +50.8% | 31,608 | +36.0% | 0.00% | – |
| Q2 2022 | $457,000 | -53.7% | 23,244 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $987,000 | -20.5% | 23,305 | +19.1% | 0.00% | 0.0% |
| Q4 2021 | $1,242,000 | +27.4% | 19,570 | +17.9% | 0.00% | 0.0% |
| Q3 2021 | $975,000 | +200.9% | 16,597 | +148.0% | 0.00% | – |
| Q2 2021 | $324,000 | -14.7% | 6,691 | -31.6% | 0.00% | – |
| Q1 2021 | $380,000 | -43.9% | 9,784 | -10.4% | 0.00% | – |
| Q4 2020 | $677,000 | – | 10,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |